Lanzafen (Olanzapine)

Olanzapine works by blocking dopamine D2 and serotonin 5‑HT2A receptors in the brain, which moderates neurotransmitter activity linked to psychosis and mood regulation. This receptor antagonism helps improve thought processes, perception, and emotional stability.

The dose of Lanzafen is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are made according to clinical guidelines and the patient’s specific therapeutic needs.

Safety data for olanzapine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs possible risks to the fetus or infant, and decisions are made in consultation with a healthcare professional.

To order Lanzafen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both Lanzafen (olanzapine) and risperidone are atypical antipsychotics, but olanzapine tends to have a higher propensity for metabolic side effects such as weight gain, while risperidone may cause more prolactin elevation. Choice depends on patient profile, efficacy, and tolerability considerations.

Lanzafen tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Lanzafen is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare provider.

Serious risks include neuroleptic malignant syndrome, severe hyperglycaemia, agranulocytosis, and tardive dyskinesia. Patients should be monitored for fever, muscle rigidity, rapid changes in blood glucose, signs of infection, or involuntary movements, and seek immediate medical attention if they occur.

Lanzafen should not be used by individuals with known hypersensitivity to olanzapine or any tablet excipients, those with severe central nervous system depression, or patients with uncontrolled narrow‑angle glaucoma. Caution is also advised in patients with a history of cardiovascular disease or metabolic disorders.